• SIGN IN
  • GET HELP
  •  

    Webinar Details


    Event Type

    Live Online

    Date

    Wednesday, July 3, 2019

    Time

    8:00 PM - 9:30 PM ET

    Location

    PharmCon Webinar Studio (freeCE.com)

    Credits

    1.5 Contact Hour(s)

    Target Audience

    Pharmacist, Pharmacy Technician

    Cost

    $0.00

    • Overview

      Chronic constipation, when broadly defined as fewer than three defecations weekly, affects about one in six Americans. The prevalence is higher in the elderly population, with some studies suggesting that 25% of individuals older than 65 have constipation.Although new-onset constipation, especially in elders, can be a sign of systemic pathology (e.g. malignancy), the overwhelming majority of those who suffer from this disorder have no discernible mucosal or structural cause and this disorder is most commonly referred to as functional constipation.  A significant segment of patients with this disorder have drug-induced constipation.Many drugs including anticholinergic drugs and calcium channel blockers may cause or contribute to constipation, but probably the most important cause of drug induced constipation is opioid induced constipation (OIC). The use of opioids for both acute and chronic pain has risen significantly in the past 20 years and accompanying this increase in opioid use has been an awareness of opioid induced bowel dysfunction.

       


      Handouts

      Slide Document 19085L01_6pp.pdf
      Slide Document 19085L01_2pp.pdf





      Financial Support By

      Bausch Health
    • Pharmacist

      Review the basic epidemiology and etiology of constipation in patients prescribed opioid analgesics.
      Outline the pharmacological options for the management of OIC (pharmacologic profiles, efficacy, side effects, & adverse events).
      Identify proactive actions pharmacists can take to screen patients and preemptively manage or minimize OIC.

      Pharmacy Technician

      Review the basic epidemiology and etiology of constipation in patients prescribed opioid analgesics.
      Outline the pharmacological options for the management of OIC (pharmacologic profiles, efficacy, side effects, & adverse events).
      Identify proactive actions pharmacists can take to screen patients and preemptively manage or minimize OIC.
    • Repeat Presentation

      This presentation was last given on 7/3/2019 8:00 PM

      Future Airings

      There are no future airings of this activity scheduled at this time.

    • Activity Type

      Knowledge

      CE Broker

      20-719956

      Universal Activity Number

      Pharmacist 0798-0000-19-085-L01-P

      Pharmacy Technician 0798-0000-19-085-L01-T

      ACPE PharmCon is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education.

      PharmCon, Inc. is an approved course provider for continuing education for nurses by the Florida Board of Nursing. PharmCon is also recognized by the California Board of Nursing as a provider of nursing programs.

      In order to obtain a Statement of Credit, attendees must answer poll questions and complete a program evaluation. Attendees may immediately print their Statement of Credit or leave them stored on the website.

    • Faculty

      Geoffrey  Wall, PharmD, FCCP, BCPS
      Professor of Pharmacy Practice, Drake University, Internal Medicine Clinical Pharmacist, Iowa Methodist Medical Center

    HARDWARE REQUIREMENTS
    Standard Windows/Mac System
    iPad or iPhone
    Minimum screen resolution: 1024x768
    Speakers or headphones
     


    SOFTWARE REQUIREMENTS
    Microsoft Edge
    Internet Explorer 8.0 or higher
    Google Chrome
    Safari
    Firefox 3.0.3 or higher


    NETWORK REQUIREMENTS
    Broadband Internet Connection:
    T1, Hi-speed DSL or Cable
    4G cellular connection
     
     

    This continuing education activity is held as copyright by PharmCon, Inc. Through this notice, PharmCon, Inc. grants permission of its use for educational purposes only. These materials may not be used, in whole or in part, for any commercial purposes without prior permission in writing from the copyright owner(s).




    Computer sharing is NOT permitted due to accreditation guidelines on activity monitoring. Credit is earned by one user per device.